CLINICAL_TRIALS
withdrawal
· 2024-06-04
Clinical Trial Update: PLAsticity, Security and Tolerance to Intermittent Hypoxic Conditioning Following Stroke [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial investigating intermittent hypoxic conditioning to enhance neural plasticity after ischemic stroke has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital, Grenoble | Conditions: Stroke, Ischemic, Stroke Sequelae | Phase 1, Phase 2 | Status: WITHDRAWN